title: Lipid abnormalities in HIV-infected patients are not correlated with lopinavir plasma concentrations.
authors.forename: Carlo
authors.initials: C
authors.lastname: Torti
authors.forename: Eugenia
authors.initials: E
authors.lastname: Quiros-Roldan
authors.forename: Mario
authors.initials: M
authors.lastname: Regazzi-Bonora
authors.forename: Andrea
authors.initials: A
authors.lastname: De Luca
authors.forename: Sergio
authors.initials: S
authors.lastname: Lo Caputo
authors.forename: Simona
authors.initials: S
authors.lastname: Di Giambenedetto
authors.forename: Andrea
authors.initials: A
authors.lastname: Patroni
authors.forename: Paola
authors.initials: P
authors.lastname: Villani
authors.forename: Valeria
authors.initials: V
authors.lastname: Micheli
authors.forename: Giampiero
authors.initials: G
authors.lastname: Carosi
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000097:blood / Q000302:isolation & purification / Q000627:therapeutic use; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods; D005260:Female; D015658:HIV Infections / Q000097:blood*; D006801:Humans; D008055:Lipids / Q000097:blood*; D061466:Lopinavir; D008297:Male; D008659:Metabolic Diseases / Q000097:blood* / Q000209:etiology*; D011744:Pyrimidinones / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015203:Reproducibility of Results
chemical_list: D019380:Anti-HIV Agents; D008055:Lipids; D011744:Pyrimidinones; D061466:Lopinavir